Agios Pharmaceuticals Current Ratio 2012-2019 | AGIO
Agios Pharmaceuticals Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2019-09-30 | $0.49B | $0.09B | 5.30 |
2019-06-30 | $0.53B | $0.09B | 5.96 |
2019-03-31 | $0.56B | $0.08B | 6.89 |
2018-12-31 | $0.61B | $0.09B | 6.56 |
2018-09-30 | $0.70B | $0.09B | 8.21 |
2018-06-30 | $0.75B | $0.09B | 8.88 |
2018-03-31 | $0.80B | $0.08B | 10.75 |
2017-12-31 | $0.45B | $0.10B | 4.69 |
2017-09-30 | $0.53B | $0.09B | 6.00 |
2017-06-30 | $0.61B | $0.09B | 6.46 |
2017-03-31 | $0.51B | $0.08B | 6.15 |
2016-12-31 | $0.56B | $0.09B | 6.33 |
2016-09-30 | $0.60B | $0.08B | 7.70 |
2016-06-30 | $0.48B | $0.07B | 7.20 |
2016-03-31 | $0.33B | $0.05B | 7.31 |
2015-12-31 | $0.34B | $0.05B | 6.38 |
2015-09-30 | $0.37B | $0.05B | 7.47 |
2015-06-30 | $0.39B | $0.05B | 8.63 |
2015-03-31 | $0.36B | $0.04B | 10.01 |
2014-12-31 | $0.36B | $0.06B | 5.89 |
2014-09-30 | $0.25B | $0.04B | 7.06 |
2014-06-30 | $0.25B | $0.05B | 5.49 |
2014-03-31 | $0.17B | $0.03B | 5.06 |
2013-12-31 | $0.17B | $0.04B | 4.60 |
2013-09-30 | $0.20B | $0.04B | 5.32 |
2013-06-30 | $0.10B | $0.04B | 2.77 |
2013-03-31 | $0.00B | 0.00 | |
2012-12-31 | $0.00B | 0.00 | |
2012-09-30 | $0.00B | 0.00 | |
2012-06-30 | $0.00B | 0.00 | |
2011-12-31 | $0.00B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $2.411B | $0.094B |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Medtronic (MDT) | Ireland | $151.583B | 20.94 |
Abbott Laboratories (ABT) | United States | $151.168B | 27.57 |
Stryker (SYK) | United States | $76.313B | 25.66 |
Boston Scientific (BSX) | United States | $61.440B | 29.00 |
Baxter (BAX) | United States | $42.463B | 25.75 |
Essilor Luxottica (ESLOY) | France | $33.468B | 0.00 |
Zimmer Biomet Holdings (ZBH) | United States | $30.550B | 19.17 |
Terumo (TRUMY) | Japan | $27.062B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $25.531B | 0.00 |
Coloplast (CLPBY) | Denmark | $25.294B | 39.03 |
ResMed (RMD) | United States | $21.653B | 39.94 |
Smith & Nephew SNATS (SNN) | United Kingdom | $19.279B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
Insulet (PODD) | United States | $11.373B | 541.06 |
Bio-Rad Laboratories (BIO) | United States | $11.201B | 53.76 |
DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
Hill-Rom Holdings (HRC) | United States | $7.203B | 21.24 |
Perrigo (PRGO) | Ireland | $7.117B | 13.27 |
Canopy Growth (CGC) | Canada | $6.501B | 0.00 |
Haemonetics (HAE) | United States | $6.146B | 41.53 |
Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
NuVasive (NUVA) | United States | $3.890B | 30.64 |
ICU Medical (ICUI) | United States | $3.830B | 24.97 |
Neogen (NEOG) | United States | $3.545B | 59.33 |
Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.165B | 0.00 |
GW Pharmaceuticals (GWPH) | United Kingdom | $3.121B | 0.00 |
Quidel (QDEL) | United States | $2.954B | 28.04 |
Aurora Cannabis (ACB) | Canada | $2.648B | 0.00 |
National Vision Holdings (EYE) | United States | $2.432B | 54.89 |
Cardiovascular Systems (CSII) | United States | $1.577B | 0.00 |
InMode (INMD) | Israel | $1.516B | 0.00 |
AtriCure (ATRC) | United States | $1.226B | 0.00 |
Aphria (APHA) | $1.187B | 0.00 | |
VAREX IMAGING (VREX) | United States | $1.162B | 23.28 |
Phibro Animal Health (PAHC) | United States | $0.994B | 18.61 |
NanoString Technologies (NSTG) | United States | $0.944B | 0.00 |
Lantheus Holdings (LNTH) | United States | $0.802B | 20.04 |
Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 29.55 |
TG Therapeutics (TGTX) | United States | $0.709B | 0.00 |
Quanterix (QTRX) | United States | $0.705B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $0.698B | 39.25 |
PetIQ (PETQ) | United States | $0.675B | 16.46 |
Omeros (OMER) | United States | $0.655B | 0.00 |
Cerus (CERS) | United States | $0.574B | 0.00 |
Surmodics (SRDX) | United States | $0.570B | 59.24 |
HEXO (HEXO) | $0.537B | 0.00 | |
OraSure Technologies (OSUR) | United States | $0.492B | 29.52 |
Owens & Minor (OMI) | United States | $0.474B | 17.53 |
MacroGenics (MGNX) | United States | $0.474B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.405B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.396B | 28.71 |
Meridian Bioscience (VIVO) | United States | $0.396B | 13.62 |
BioLife Solutions (BLFS) | United States | $0.331B | 134.92 |
Zynex (ZYXI) | United States | $0.329B | 37.22 |
Bovie Medical (APYX) | United States | $0.275B | 0.00 |
Neptune Wellness Solutions (NEPT) | Canada | $0.269B | 0.00 |
United Health Products (UEEC) | United States | $0.249B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.242B | 25.52 |
Vapotherm (VAPO) | United States | $0.227B | 0.00 |
Repro-Med Systems (KRMD) | United States | $0.195B | 0.00 |
Liberty Health Sciences (LHSIF) | Canada | $0.192B | 0.00 |
Green Organic Dutchman Holdings (TGODF) | Canada | $0.164B | 0.00 |
Chimerix (CMRX) | United States | $0.151B | 0.00 |
Female Health (VERU) | United States | $0.148B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
Cytosorbents (CTSO) | United States | $0.128B | 0.00 |
Fonar (FONR) | United States | $0.128B | 9.03 |
MTech Acquisition (KERN) | United States | $0.114B | 0.00 |
United-Guardian (UG) | United States | $0.091B | 23.15 |
Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
Nephros (NEPH) | United States | $0.064B | 0.00 |
Surface Oncology (SURF) | United States | $0.062B | 0.00 |
ImmuCell (ICCC) | United States | $0.037B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
Senestech (SNES) | United States | $0.017B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |